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ABSTRACT: A library of over twenty, mainly aryl or heteroaryl, N-methyliminodiacetic acid 
(MIDA) boronates has been synthesized. A rapid microwave-mediated (MW) method (5-10 
mins) has been developed using polyethylene glycol 300 (PEG 300) as solvent. However, 
acetonitrile (MeCN) and dimethylformamide (DMF) were found to be alternative solvents, the 
latter especially for 2-substituted aryl boronic acids.   
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 Introduction 
The twelve Principles Of Green Chemistry, encompassing inter alia, atom economy, less 
hazardous chemical syntheses, safer solvent use, improved energy efficiency and the use of 
renewable feedstocks, are invaluable guidelines for evaluating the greenness in the design 
and implementation of any  new process or technology.1–3 
Burke’s group has pioneered MIDA boronate chemistry, showing these compounds to be 
orthogonal to boronic acids in Suzuki-Miyaura (SM) reactions. By virtue of an sp3 hybridized 
boron, MIDA boronates, Fig. 1,4 are less prone to transmetallation, exemplified by the 
selective cross-coupling of bromophenyl MIDA boronates with p-tolylboronic acid, affording 
biaryl-MIDA boronates, under anhydrous conditions.5  
 
Fig. 1 sp2 vs sp3 boronic acids and derivatives in cross-couplings 
 
The scope of MIDA boronates as protecting groups has been underlined in other related 
coupling reactions e.g. Negishi, Heck, Sonogashira, Stille and Buchwald–Hartwig 
amination,6–10 as well as in various functional group interconversions on arenes. Examples of 
the latter include oxidations under Jones or Swern conditions or cycloisomerization of 
arylethynyl MIDA boronates.11,12 These allow for greener, multistep telescopic reactions with 
an in situ cleavage of the MIDA boronate, enabling a second coupling, minimising work-up 
and solvent usage in these one-pot processes. This is desirable in medicinal chemistry as the 
deployment of faster reaction times, fewer reaction steps and lower solvent volumes is 
desirable.13 MIDA boronates are crystalline solids that are air stable and silica-gel column-
 compatible14 and may also be used as “handles” to enhance the stability of otherwise unstable 
boronic acids.15–18  
Due to their advantageous attributes, many MIDA boronates are, not surprisingly, 
commercially available.19 Current methods of MIDA boronate synthesis include (Figure 2); 
i) metallation to form an organolithium or Grignard reagent, followed by borylation with 
trimethyl or triisopropyl-borate to form the corresponding boronate followed by in situ 
esterification with MIDA in dimethylsufoxide (DMSO). ii)  Electrophilic arene borylation 
followed by an overnight MIDA esterification with the bis-trimethylsilyl ester of MIDA, the 
disodium salt of MIDA or MIDA alone. iii) MIDA esterification of a boronic acid with 4-
methylmorpholine-2,6-dione (MIDA anhydride). iv) Esterification of a boronic acid with 
MIDA in DMSO/benzene or toluene via an 8 h azeotropic removal of water with a Dean 
Stark trap. v) Esterification of a boronic acid with MIDA in DMF at 85 oC for 18 h, hitherto 
deemed to be the method of choice.20–23 
 
 
 Figure 2.  MIDA arylboronate synthesis 
 
Many current synthetic methods towards MIDA boronates require a multistep process, large 
solvent volume or an extensive period of heating. Given the above, the increasing numbers of 
green processes employing MIDA boronates would be far more attractive were a general, 
scalable, efficient process for preparing the starting material available. Herein, we describe 
our efforts aimed at reducing reaction times and solvent usage. Moreover, the use of 
microwave chemistry24–26 for enabling quick, more efficient reactions was anticipated to be 
advantageous in the synthesis MIDA boronates 2 from their boronic acid precursors. 
We wished to form the MIDA ester of 4-fluoro-3-formyl boronic acid 1i using the standard 
literature method of choice. However, we were frustrated with the reaction times involved 
and, hence, examined the use of microwave-mediated methods. Hence, a rapid screen of 
(minimal volume) solvent and potential additives was performed to ascertain the best 
conditions. This method was particularly propitious for screens employing small volumes of 
deuterated NMR solvents such that, upon cooling, the reaction mixture was transferred 
directly to an NMR tube then spectrometer for inspection. Employing one equivalent of 
MIDA, a microwave-mediated route using a short hold time of 5 mins was attempted and 
results are summarised in Table 1. 
 
Table 1 Rapid solvent screen for test reaction 
 
Entry  Solvent / Additive  % 
 Conversiona 
1 Acetonitrile-d3  95
 
2 Acetonitrile-d3 + 3Å 
molecular sieves  
93 
3 Water 5b 
4 DMSO-d6 60
 
5 DMSO-d6  + 4Å molecular 
sieves 
0 
6 DMF dry 97 
7 DMF reagent grade  72 
8 PEG 300 69b 
a calculated from 1H NMR integration of crude mixture. bisolated yield.  
 
Table 1 shows that, apart from water (entry 3), DMSO gave the poorest results out of the 
solvents trialled, and reactions mixtures tended to blacken, with dimethylsulphide odour 
detected (entries 4, 5). This was more noticeable when molecular sieves were used as they are 
known to be Lewis acidic and could increase decomposition (entry 5) and large amounts of 
impurities in the crude NMR were observed.27 It is notable that dry DMF was the best solvent 
(entry 6). We concluded that small amounts of water in reagent grade DMF (entry 7) may 
lead to in situ MIDA ester cleavage due to possible (basic) dimethylamine generation.28 The 
result employing acetonitrile (entry 1), although comparable to that of Entry 6, was deemed 
to be the most promising, due to the reduced toxicity and lower boiling point of this 
solvent.29,30Interestingly, the use of molecular sieves (entry 2) did not push the reaction to 
completion.   
 To test the reaction scope, we next synthesised a small library of MIDA boronates using the 
initial solvent of choice, acetonitrile, and employing a short, 5 min, reaction hold time, see 
Table 2 (General method A, orange highlight). Yields, in general, were good to excellent, e.g. 
2a, 2c, 2o and the reaction showed good functional group tolerance. A simple alkyl MIDA 
boronate 2m was formed in near quantitative yield. However, 2b was formed in a low yield, 
for unknown reasons, and one other notable exception is compound 2p, which we were 
unable to synthesize. We hypothesized the lack of reaction may at least be partly due to the 
presence of two ortho substituents flanking the boronic acid functionality and that a higher 
boiling point solvent and/or extended reaction times might enable this reaction. 
 For 2d, 2h and 2o similar yields were achieved when the reactions were run on a small (1 
mmol) or large (gram) scale. However, for the high scale reactions, some technical 
adjustments were required; for example, a 5 mmol scale reaction in a 35 mL CEM microwave 
vial often gave rise to increased pressurisation, due to a reduction in relative head space in the 
closed system. In order to resolve this, a like for like comparative to the original 1 mmol 
conditions was implemented, enabling the same relative head space. Hence, a 1 mmol scale 
reaction was conducted in a 10 mL vial whereas a 3.5 mmol scale reaction was performed in 
a 35 mL vial. Given that we had no access to 50 mL microwave vials, we ran 5 mmol scale 
reactions under open vessel microwave conditions.  
Next, we turned our attention to DMF as solvent and increased the reaction time to 10 min, 
as a rapid screen showed 5 mins to lead to incomplete reactions (Table 2 General method B, 
red highlight).  Gratifyingly, 2p was now formed in 62% yield and a series of 2-substituted 
aryl and heteroaryl MIDA boronates was synthesized, mostly in moderate to good yields. 
Relatively poor yields were recorded for the 2-phenol derivative 2v and the chloropyridine 2t 
whereas 2y was not formed at all. Reaction optimisation studies, beyond the scope of the 
current work, may lead to improved yields. On increasing the scale of these conditions we 
 found, comparable or slightly lower yields for 2p, 2s and 2w. Due to the higher boiling point 
of DMF, compared with acetonitrile, it allowed us to work on a larger 5 mmol scale in a 
closed vessel, and even an open vessel on a 10 mmol scale in the case of 2s. We also note an 
acceptable 44% yield for the somewhat elusive benzaldehyde derivative 2q.23  
Having considerably improved upon conventional reaction times for MIDA boronate 
synthesis using microwave chemistry, our next iteration needed to address the issues of 
solvent suitability. PEG 300 was considered as a worthy candidate solvent as it has similar 
properties to DMSO, in terms of polarity and hydrogen bond acceptor properties, as 
highlighted by Jessop, in two Kamlet–Taft plots of common solvents.31 It also has the desired 
green solvent properties, viz. negligible vapour pressure, low flammability, reduced 
environmental damage adding to the advantage of a complete toxicity report and it is 
approved by the FDA for human consumption.32 Finally, we already found it to be suitable 
for microwave mediated MIDA boronate synthesis (entry 8, Table 1). 
Hence, yields in PEG 300 were generally good but, again, some technical adjustments were 
necessary at the start. The higher viscosity of the medium led to difficulty in stirring the 
reaction during microwave irradiation, sometimes leading to overheating by up to 40 oC. This 
was averted by limiting the maximum power on the microwave’s dynamic setting to 40 W. A 
few trends need to be outlined (Table 2 General method C, green highlight); yields for 2-
substituted MIDA boronates tend to be lower than those obtained in DMF, e.g. the poorer 
yields for 2s (51% vs 97%), 2u (60% vs 83%) or the significantly lower yields for 2p (14% 
vs 62%), 2q (9% vs 44%) in PEG 300 signify that DMF would be a solvent of choice in their 
synthesis. In PEG 300 comparable yields for the synthesis of 2h were obtained when 
performed on a low to multigram scale and an isolated yield of 82% for 2t was observed. The 
low vapour pressure of PEG 300 made scale up easy and we no longer experienced a 
limitation in vial size, as noted for acetonitrile (vide supra). Product 2h was easily made in an 
 open vessel MW reaction on a 10 mmol scale and the work up procedure using PEG 300 
proved easy; precipitation of the pure MIDA boronate product, after cooling, was achieved 
using water. After collection by filtration the product was washed with minimal water to 
remove any residual solvent. 
Compatibility issues with the attempted MIDA protection of 2-heterocyclic boronic acids, 
which are of particular interest for slow release couplings, were encountered.18 Test reactions 
were carried out on N-Boc-pyrrole-2-boronic acid, 2-furanylboronic acid and 2-
thienylboronic acid, but 1H NMR inspection of the crude material in these three cases showed 
a large amount of impurities, and these were not pursued any further.   
 
Table 2 Isolated yields (%) for MIDA boronates 
 
  
a1 mmol scale, b3.5 mmol scale, c5 mmol scale, d10 mmol scale 
 
Finally, we have checked the applicability of this MIDA forming reaction with other boron-
containing precursors and selected dichlorophenylborane 3n as a precursor (Table 3). The 
latter, being highly reactive, was not suitable for use in the aprotic solvent, PEG 300, (entry 
1) and best yields were obtained in DMF (entry 3), which are comparable to those obtained 
using phenylboronic acid (entry 5). 
 
Table 3. Dichlorophenylborane as a precursor to the MIDA analogue 2n. 
 
  
Entry  Solvent  Method isolated yield (%) 
1 PEG 300 5 min MW heating 130 
o
C 0
 
2 MeCN dry 5 min MW heating 130 
o
C 39
 
3 DMF dry 5 min MW heating 130 
o
C 63
 
4 DMF dry 24 h rt  12
 
5
a
 PEG 300 5 min MW heating 130 
o
C 55
 
a 
entry 2n, Table 2, (from PhB(OH)2), for comparison. 
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Conclusion 
A rapid microwave-mediated synthesis of a library of MIDA boronates has been developed. In many 
cases this reaction is high yielding, uses minimal solvent and reaction times, can be performed on a 
multigram scale and is tolerant of a range of functional groups. At best, performed in PEG 300 as 
solvent, this protocol should now represent the method of choice for the synthesis of synthetically-
important MIDA boronates and used in the synthesis of bioactive compounds. Results in this respect 
will be reported in due course. We have also found that this reaction can be used with a 
dichlorophenylborane precursor. Moreover, full characterisation data for these products, many of which 
are commercially available, are provided. 
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General Experimental Methods 
Solvents and reagents were purchased from commercial suppliers and used without further purification. 
Boronic acids were typically purchased, and used as such, from Sigma Aldrich or Boron Molecular. 
Reactions were heated using a CEM discovery microwave fitted with an explorer unit; ensure a 
ventilated fumehood with the sash lowered is used as these reactions are under high pressure and 
temperature.  NMR spectra were recorded on a Varian 500 MHz or 400 MHz spectrometer. Chemical 
shifts are reported in ppm and are referenced to the residual solvent peak or to TMS used as an internal 
standard; note that in some cases the C-B bond is not detectable in the 13C NMR.25 LCMS were ran with 
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a 5 µm C18 110 Å column. Percentage purities were performed using a 30 min method in 
water/acetonitrile with 0.1% formic acid (5 min at 5%, 5%-95% over 20 min, 5 min at 95%) with the 
UV set to 254 nm. High resolution mass spectrometry (HRMS) was done either internally or by the 
National Mass Spectrometry Facility, University of Swansea on a LTQ Orbitrap XL. A number of the 
products described below are commercially available or known, e.g. in patents. In these cases, 1H, 13C, 
HRMS and % purity data are presented since in many cases these data are not published. For 
compounds that appear to be novel, more analytical data are presented including 11B NMR. 
General procedure for MIDA boronate formation with acetonitrile (General Method A) 
The boronic acid (1 mmol) was added to a 10 mL microwave vial equipped with a magnetic stirrer, and 
then acetonitrile (1 mL) was added, followed by methyliminodiacetic acid (MIDA) (147 mg, 1 mmol). 
The Teflon cap was added and the reaction was heated using the dynamic heating method, with the 
maximum power set to 300 W, max pressure 250 psi, max temperature 130 oC, high stirring throughout 
and power max turned off. This method was used to hold the reaction mixture at 130 oC for 5 min. After 
cooling, the magnetic stirrer was retrieved and the acetonitrile was removed under reduced pressure 
giving a crude white powder. This crude material was first triturated via sonication with deionised water 
(5 mL), cooled in an ice bath and collected by filtration and washed with cold water (5 mL). This solid 
was then further triturated with diethyl ether (5 mL), cooled in an ice bath, collected by filtration and 
washed with diethyl ether (5 mL) giving pure product as a white precipitate (if not otherwise quoted) 
which was air dried.  
Notes: The 3.5 mmol scale reaction was done using a 35 mL microwave vial, with the same heating 
profile. 
General procedure for MIDA boronate formation with DMF (General Method B) 
The boronic acid (1 mmol) was added to a 10 mL microwave vial equipped with a magnetic stirrer, 
followed by methyliminodiacetic acid (MIDA) (1 mmol) and dry DMF (1 mL) was added to the vial. 
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The Teflon cap was added and the reaction was heated using the dynamic heating method, with max 
power set to 300 W, max pressure 300 psi, max temperature 130 oC, high stirring throughout and power 
max turned off. This method was used to hold the reaction mixture at 130 oC for 10 min. 
After cooling, the DMF was removed under reduced pressure giving crude yellow oil. The latter was 
triturated via sonication with deionised water (5 mL), cooled in an ice bath and collected by filtration 
and washed with cold water (5 mL). This solid was then further triturated with diethyl ether (5 mL), 
cooled in an ice bath, collected by filtration and washed with diethyl ether (5 mL) then air dried giving 
pure product as a white precipitate.  
General procedure for MIDA boronate formation with PEG 300 (General Method C) 
The boronic acid (1 mmol) was added to a 10 mL microwave vial equipped with a magnetic stirrer, and 
then PEG 300 (1 mL) was added followed by methyliminodiacetic acid (MIDA) (147 mg, 1 mmol). The 
Teflon cap was added and the reaction was heated using the dynamic heating method, with max power 
set to 40 W, max pressure 250 psi, max temperature 130 oC, high stirring throughout and power max 
turned off. This method was used to hold the reaction mixture at 130 oC for 5 min. 
After cooling, the mixture was added to water (9 mL). This mixture was stirred forming a white 
precipitate, then cooled in an ice bath allowing flocculation, then collected by filtration and washed with 
cold water (5 mL). The precipitate was allowed to dried in an oven set to 100 oC, giving pure product as 
a white precipitate (if not otherwise quoted). 
Notes: The 5 mmol scale reaction was performed using a 35 mL microwave vial and the 10 mmol scale 
was carried out using a 100 mL round bottomed flask with a small air condenser attached with the open 
vessel attenuator installed.  The heating parameters were kept the same but the hold time was changed to 
7.5 min for the 5 mmol scale and 10 min for the 10 mmol scale reactions. 
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3-Hydroxyphenyl MIDA boronate 2a.  Made following General Method A.  Yield: 199 mg (80%). CAS 
Number 1257724-90-5. 1H NMR (500 MHz, DMSO-d6) δ 9.26 (s, 1H), 7.25 (d, J = 8.0 Hz, 1H), 6.96 – 
6.90 (m, 2H), 6.84 (d, J = 8.0 Hz, 1H), 4.40 (d, J = 17.1 Hz, 2H), 4.18 (d, J = 17.1 Hz, 2H), 2.58 (s, 3H). 
13C NMR (126 MHz, DMSO-d6) δ 169.3, 156.7, 128.8, 122.9, 119.0, 115.8, 61.7, 47.5. 
11B NMR (128 
MHz, DMSO-d6) δ 11.68. LCMS purity >99% (UV), Ret. time = 11.61 min. HRMS-ESI (m/z) found 
250.0878, calcd for [C11H12
10BNO5H]
+ 250.0881. 
 
4-Hydroxyphenyl MIDA boronate 2b. Made following General Method A. Yield: 87 mg (35%). CAS 
Number 1312788-59-2. 1H NMR (500 MHz, Acetonitrile-d3) δ 7.33 (d, J = 8.0 Hz, 2H), 6.93 (s, 1H), 
6.82 (d, J = 8.0 Hz, 2H), 4.02 (d, J = 17.1 Hz, 2H), 3.84 (d, J = 17.1 Hz, 2H), 2.48 (s, 3H). 13C NMR 
(100 MHz, Acetonitrile-d3) δ 169.6, 159.0, 135.0, 115.9, 62.7, 48.4. 
11B NMR (128 MHz, Acetonitrile-
d3) δ 11.60. LCMS purity >99% (UV), Ret. time = 11.14 min. HRMS-ESI (m/z) found 272.0700, calcd 
for [C11H12
10BNO5Na]
+ 272.0701. 
3-Acetamidophenyl MIDA boronate 2c.  Made following General Method A. Yield: 230 mg (1 mmol 
scale, 79%), 861 mg (3.5 mmol scale, 85%) as a pink precipitate. Made following General Method C. 
Yield: 223 mg (77%) as a pink precipitate. 1H NMR (500 MHz, DMSO-d6) δ 9.87 (s, 1H), 7.79 – 7.74 
(m, 1H), 7.46 (s, 1H), 7.31 – 7.24 (m, 1H), 7.12 – 7.06 (m, 1H), 4.33 (d, J = 17.2 Hz, 2H), 4.09 (d, J = 
17.2 Hz, 2H), 2.49 (s, 3H), 2.02 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 169.2, 168.1, 138.7, 128.0, 
127.0, 122.9, 119.7, 61.6, 47.5, 23.9. 11B NMR (128 MHz, DMSO-d6) δ 11.34.
 LCMS purity >99% 
(UV), Ret. time = 11.76 min. HRMS-FTMS (m/z) found 290.1180, calcd for [C13H15
10BN2O5H]
+ 
290.1183. 
4-Acetamidophenyl MIDA boronate 2d. Made following General Method A. Yield:  232 mg (1 mmol 
scale, 80%), 768 mg (3.5 mmol scale, 76%) as a brown crystalline solid. Made following General 
Method C. Yield:  252 mg (1 mmol scale, 87%) as a brown crystalline solid. 1H NMR (500 MHz, 
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DMSO-d6) δ 9.90 (s, 1H), 7.55 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.30 (d, J = 17.2 Hz, 2H), 
4.08 (d, J = 17.2 Hz, 2H), 2.48 (s, 3H), 2.04 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 169.3, 168.2, 
139.9, 132.8, 118.2, 61.7, 47.5, 24.0. 11B NMR (128 MHz, DMSO-d6) δ 10.36. LCMS purity >99% 
(UV), Ret. time = 11.37 min HRMS-FTMS (m/z) found 290.1181, calcd for [C13H15
10BN2O5H]
+ 
290.1183..  
3-Formylphenyl MIDA boronate 2e. Made following General Method A. Yield: 200 mg (76%). Made 
following General Method C. Yield: 264 mg (51%). CAS Number 1257642-72-0. 1H NMR (500 MHz, 
DMSO-d6) δ 10.04 (s, 1H), 8.0 (s, 1H), 7.91 (d, J = 7.5 Hz, 1H), 7.78 (d, J = 7.5 Hz, 1H), 7.60 (appt, J = 
7.5 Hz, 1H), 4.37 (d, J = 17.2 Hz, 2H), 4.17 (d, J = 17.2 Hz, 2H), 2.53 (s, 3H). 13C NMR (126 MHz, 
DMSO-d6) δ 193.5, 169.2, 138.6, 135.5, 133.9, 129.8, 128.4, 62.0, 47.7. 
11B NMR (128 MHz, DMSO-
d6) δ 11.31. LCMS purity UV = 98%, Ret. time = 13.45 min. HRMS-ESI (m/z) found 284.0701, calcd 
for [C12H12
10BNO5Na]
+ 284.0701. 
4-Formylphenyl MIDA boronate 2f. Made following General Method A. Yield: 264 mg (99%). Made 
following General Method C. Yield: 227 mg (87%). CAS Number 1257650-77-3. 1H NMR (500 MHz, 
Acetonitrile-d3) δ 10.04 (s, 1H), 7.89 (d, J = 8.0 Hz, 2H), 7.72 (d, J = 8.0 Hz, 2H), 4.10 (d, J = 17.1 Hz, 
2H), 3.93 (d, J = 17.1 Hz, 2H), 2.52 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 193.4, 169.2, 136.5, 
133.1, 128.5, 62.0, 47.7. 11B NMR (128 MHz, DMSO-d6) δ 10.82. LCMS purity >99% (UV), Ret. time 
= 11.76 min. HRMS-ESI (m/z) found 284.0699, calcd for [C12H12
10BNO5Na]
+ 284.0701. 
3-Bromophenyl MIDA boronate 2g. Made following General Method A. Yield: 274 mg (88%). Made 
following General Method C. Yield: 218 mg (70%). CAS Number 943552-25-8. 1H NMR (500 MHz, 
Acetonitrile-d3) δ 7.65 (s, 1H), 7.63 – 7.59 (m, 1H), 7.53 – 7.48 (m, 1H), 7.37 – 7.33 (m, 1H), 4.07 (d, J 
= 17.1 Hz, 2H), 3.91 (d, J = 17.1 Hz, 2H), 2.53 (s, 3H). 13C NMR (126 MHz, Acetonitrile-d3) δ 169.3, 
136.2, 133.2, 132.3, 131.0, 123.4, 63.0, 48.7. 11B NMR (128 MHz, Acetonitrile-d3) δ 11.31. LCMS 
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purity UV >99%, Ret. time = 16.73 min. HRMS-ESI (m/z) found 333.9851, calcd for 
[C11H11
10BBrNO4Na]
+ 333.9857. 
4-Bromophenyl MIDA boronate 2h. Made following General Method A. Yield: 278 mg (1 mmol scale, 
89%), 861 mg (3.5 mmol scale, 79%). Made following General Method C. CAS Number 943552-04-3. 
Yield: 259 mg (1 mmol scale, 83%), 1.127 g (5 mmol scale, 72%), 2.551 g (10 mmol scale, 82%). 1H 
NMR (500 MHz, Acetonitrile-d3) δ 7.55 (d, J = 8.0 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 4.07 (d, J = 17 
Hz, 2H), 3.89 (d, J = 17 Hz, 2H), 2.51 (s, 3H). 13C NMR (126 MHz, Acetonitrile-d3) δ 169.4, 135.6, 
132.0, 124.4, 62.9, 48.6. 11B NMR (128 MHz, Acetonitrile-d3) δ 11.24. LCMS purity UV >99%, Ret. 
time = 16.87 min. HRMS-ESI (m/z) found 333.9857, calcd for [C11H11
10BBrNO4Na]
+ 333.9857. 
4-Fluoro-3-formylphenyl MIDA boronate 2i. Made following General Method A. Yield: 226 mg (81%). 
Made following General Method C. Yield: 193 mg (69%). 1H NMR (500 MHz, Acetonitrile-d3) δ 10.30 
(s, 1H), 7.96 (dd, 4JFH = 7.4, 
4JHH = 2.0 Hz, 1H), 7.82 (ddd, 
3JHH =  8.3, 
4JFH = 5.6, 
4JHH = 2.0 Hz, 1H), 
7.27 (dd, 3JFH = 11.0,
 3JHH = 8.3 Hz, 1H), 4.10 (d, J = 17.2 Hz, 2H), 3.93 (d, J = 17.2 Hz, 2H), 2.54 (s, 
3H). 13C NMR (126 MHz, Acetonitrile-d3) δ 187.9 (d, 
3JFC = 6.0 Hz), 168.3, 165.0 (d, 
1JFC = 260 Hz), 
140.9 (d, 3JFC = 9 Hz), 134.0 (d, 
3JFC = 2 Hz), 123.7 (d, 
2JFC = 8.0 Hz), 116.1 (d, 
2JFC = 20 Hz), 62.1 , 
47.7. 19F NMR (376 MHz, Acetonitrile-d3) δ -110.85 (ddd, J = 12.2, 7.7, 5.1 Hz). 
11B NMR (128 MHz, 
Acetonitrile-d3) δ 10.6. LCMS purity UV = 96%, Ret. time = 14.10 min. HRMS-ESI (m/z) found 
302.0607, calcd for [C12H11
10BFNO5Na]
+ 302.0607. 
3-Fluoro-4-formylphenyl MIDA boronate 2j. Made following General Method A. Yield: 235 mg (84 %). 
Made following General Method C. Yield: 204 mg (73 %). 1H NMR (500 MHz, Acetonitrile-d3) δ 10.34 
(s, 1H), 7.87 (appt, 
3JHH,
4JFH J = 7.5 Hz, 1H), 7.49 (d, 
3JHH = 7.5 Hz, 1H), 7.43 (d, 
3JFH = 11.4 Hz, 1H), 
4.15 (d, J = 17.2 Hz, 2H), 3.98 (d, J = 17.2 Hz, 2H), 2.59 (s, 3H). 13C NMR (126 MHz, Acetonitrile-d3) 
δ 188.7 (d, 3JFC = 6.0 Hz), 169.2, 164.9 (d, 
1JFC = 258.0 Hz), 129.8, (d, 
3JFC = 4.0 Hz), 129.4, 125.7 (d, 
2JFC = 9.0 Hz), 121.3 (d, 
2JFC = 19.0 Hz), 63.2, 48.7. 
19F NMR (376 MHz, Acetonitrile-d3) δ -112.46 (dd, 
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J = 11.7, 7.3 Hz). LCMS purity UV 94%, Ret. time = 14.24 min. 11B NMR (128 MHz, Acetonitrile-d3) δ 
10.6. HRMS-ESI (m/z) found 302.0605, calcd for [C12H11
10BFNO5Na]
+ 302.0607. 
2-Fluoropyridin-5-yl MIDA boronate 2k. Made following General Method A. Yield: 152 mg (60%). 
Made following General Method C. Yield: 121 mg (48%). 1H NMR (500 MHz, DMSO-d6) δ 8.26 – 
8.23 (m, 1H), 8.03 – 7.97 (m, 1H), 7.17 – 7.13 (m, 1H), 4.36 (d, J = 17.2 Hz, 2H), 4.16 (d, J = 17.2 Hz, 
2H), 2.58 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ 169.0, 164.0 (d, 
1JFC = 236.2 Hz), 151.6 (d, 
3JFC = 
14.1 Hz), 146.4 (d, 3JFC = 7.6 Hz), 108.7 (d, 
2JFC = 35.8 Hz), 62.0, 47.7. 
19F NMR (376 MHz, DMSO-
d6) δ -68.77 (d, J = 9.0 Hz). 
11B NMR (128 MHz, DMSO-d6) δ 11.16. LCMS purity UV >99%, Ret. 
time = 12.13 min. HRMS-ESI (m/z) found 253.0789, calcd for [C10H10
10BN2O4H]
+ 253.0790. 
3-Fluorophenyl MIDA boronate 2l. Made following General Method A. Yield: 231 mg (92%). Made 
following General Method C. Yield: 171 mg (68%). CAS Number 1313614-50-4. 1H NMR (500 MHz, 
DMSO-d6) δ 7.44 – 7.38 (m, 1H), 7.26 (d, J = 7.3 Hz, 1H), 7.23 – 7.12 (m, 2H), 4.34 (d, J = 17.2 Hz, 
2H), 4.14 (d, J = 17.2 Hz, 2H), 2.53 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 169.2, 162.0 (d, 
1JFC = 
244.0 Hz), 129.8 (d, 3JFC = 7.3 Hz), 128.3 (d, 
4JFC = 2.6 Hz), 118.6 (d, 
2JFC  = 18.7 Hz), 115.6 (d, 
2JFC = 
20.8 Hz), 61.9, 47.6. 19F NMR (376 MHz, DMSO-d6) δ -114.11 (td, J = 9.6, 5.8 Hz). 
11B NMR (128 
MHz, DMSO-d6) δ 10.69. LCMS purity UV >99%, Ret. time = 15.22 min. HRMS-FTMS (m/z) found 
274.0664, calcd for [C11H11O4NBFNa]
+ 274.0664. 
Methyl MIDA boronate 2m. Made following General Method A. Yield: 171 mg (99%). Made following 
General Method C. Yield: 87 mg (51%). CAS Number 1104637-40-2. 1H NMR (500 MHz, 
Acetonitrile-d3) δ 3.92 (d, J = 17.0 Hz, 2H), 3.78 (d, J = 17.0 Hz, 2H), 2.84 (s, 3H), 0.10 (s, 3H). 
13C 
NMR (126 MHz, Acetonitrile-d3) δ 169.1, 62.6, 46.9. 
11B NMR (128 MHz, Acetonitrile-d3) δ 13.37. 
HRMS-ESI (m/z) found 194.0594, calcd for [C6H10
10BNO4Na]
+ 194.0595. 
Phenyl MIDA boronate 2n. Made following General Method A. Yield: 123 mg (53%), Made following 
General Method C. Yield: 128 mg (55%). Made following modified General Method B (PhBCl2 (Sigma 
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Aldrich) was first added dropwise to stirred MIDA in DMF in microwave vial, CAUTION, HCl 
evolution!) Yield: 147 mg (63%). CAS Number 109737-57-7.  1H NMR (500 MHz, Acetonitrile-d3) δ 
7.53 – 7.47 (m, 2H), 7.44 – 7.36 (m, 3H), 4.06 (d, J = 17.1 Hz, 2H), 3.88 (d, J = 17.1 Hz, 2H), 2.49 (s, 
3H). 13C NMR (100 MHz, Acetonitrile-d3) δ 169.6, 133.4, 130.3, 128.9, 62.8, 48.5. 
11B NMR (128 
MHz, Acetonitrile-d3) δ 10.64. LCMS purity UV >99%, Ret. time = 14.38 min. HRMS-ESI (m/z) found 
256.0750, calcd for [C11H12
10BNO4Na]
+ 256.0752. 
(E)-Styryl MIDA boronate 2o. Made following General Method A. Yield: 135 mg (52%), 480 mg (3.5 
mmol scale, 53%). Made following General Method C. Yield: 75 mg (29%). CAS Number 1152427-93-
4. 1H NMR (400 MHz, DMSO-d6) δ 7.52 – 7.47 (m, 2H), 7.39 – 7.32 (m, 2H), 7.29 – 7.24 (m, 1H), 6.83 
(d, J = 18.2 Hz, 1H), 6.28 (d, J = 18.2 Hz, 1H), 4.25 (d, J = 17.0 Hz, 2H), 4.04 (d, J = 17.0 Hz, 2H), 
2.81 (s, 3H). 13C NMR (101 MHz, DMSO) δ 169.0, 141.0, 137.8, 128.5, 127.8, 126.4, 61.3, 46.7, 39.5. 
11B NMR (128 MHz, Acetonitrile-d3) δ 10.54. LCMS purity UV = >99%, Ret. time = 1.75 min. HRMS-
FTMS (m/z) found 328.9971, calcd for [C11H10
10BBrFNO4H]
+ 328.9979. 
2-Bromo-6-fluorophenyl MIDA boronate 2p. Made following General Method B. Yield: 205 mg (62%), 
924 mg (5 mmol scale, 56%). Made following General Method C. Yield: 46 mg (14%). CAS Number 
1257650-76-2.  1H NMR (500 MHz, DMSO-d6) δ 7.49 (d, 
3JHH = 8.0 Hz, 1H), 7.36 (dd, 
3JHH  = 8.0, 8.2 
Hz, 1H), 7.19 (dd, 3JFH = 10.9,
 3JHH = 8.2 Hz, 1H), 4.42 (d, J = 17.3 Hz, 2H), 4.16 (d, J = 17.3 Hz, 2H), 
2.72 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 168.6, 166.5 (d, 
1JCF= 248.0 Hz), 132.6 (d, 
3JFC = 11 
Hz), 130.5 (d, 4JFC = 3.0 Hz), 127.8 (d, 
3JFC = 9.0 Hz), 115.2 (d, 
2JFC = 27.0 Hz), 63.0, 47.9. 
19F NMR 
(376 MHz, DMSO-d6) δ -97.67 (dd, J = 10.9, 6.3 Hz). 
11B NMR (128 MHz, DMSO-d6) δ 10.6. LCMS 
purity UV = >99%, Ret. time = 15.42 min. HRMS-FTMS (m/z) found 328.9971, calcd for 
[C11H10
10BBrFNO4H]
+ 328.9979. 
2-Formylphenyl MIDA boronate 2q. Following General Method B. Yield: 116 mg (44 %), CAS 
Number 1257651-51-6. Following General Method C. Yield: 23 mg (9 %). 1H NMR (500 MHz, 
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Acetonitrile-d3): δ 10.11 (s, 1H), 7.93 (m, 1H), 7.80 (m, 1H), 7.66 (m, 2H), 4.14 (d, J=17.8, 2H), 4.14 
(d, J=17.8, 2H), 2.68 (s, 3H). 13C NMR (126 MHz, Acetonitrile-d3):
 196.8, 169.9, 142.1, 136.8, 135.2, 
134.0, 130.7, 65.7, 50.0. 11B NMR (128 MHz, Acetonitrile-d3): 11.83. LCMS purity UV = >99 %, Ret. 
time = 12.94 min. HRMS-FTMS (m/z) found 262.0880, calcd for [C12H12
10BNO5H]
+ 262.0881. 
2-Bromophenyl MIDA boronate 2r. Made following General Method B. Yield: 224 mg (72%). Made 
following General Method C. Yield: 218 mg (70%). CAS Number 1257649-57-2. 1H NMR (500 MHz, 
Acetonitrile-d3): δ 7.67 (d, J =7.4 Hz, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.39 (dd, J = 7.4 Hz, 7.5 Hz, 1H), 
7.30 (dd, J = 7.8, 7.5 Hz, 1H), 4.13 (d, J = 17.3 Hz, 2H), 4.03 (d, J = 17.3 Hz, 2H), 2.71 (s, 3H). 13C 
NMR (126 MHz, Acetonitrile-d3):
 169.5, 137.4, 134.6, 132.4, 128.7, 128.0, 65.3, 49.6. 11B NMR (128 
MHz, Acetonitrile-d3): 11.60. LCMS purity UV = >99%, Ret. time = 15.44 min. HRMS-FTMS (m/z) 
found 333.9862, calcd for [C11H11
10BBrNO4Na]
+ 333.9857. 
2-Methoxyphenyl MIDA boronate 2s. Made following General Method B. Yield: 254 mg (97%), 1144 
mg (5 mmol scale, 87%), 2420 mg (10 mmol scale, 92%).  Made following General Method C. Yield: 
134 mg (51%). CAS Number 1257737-05-5. 1H NMR (500 MHz, Acetonitrile-d3): δ 7.56 (dd, J = 7.2, 
1.9 Hz, 1H), 7.39 (ddd, J = 8.2, 7.2, 1.9 Hz, 1H), 6.97 (m, 2H), 4.06 (d, J = 17.0 Hz, 2H), 3.95 (d, J = 
17.0 Hz, 2H), 3.77 (s, 3H), 2.61 (s, 3H). 13C NMR (126 MHz, DMSO-d6): 169.2, 162.0, 133.9, 130.7, 
120.2, 110.3, 63.2, 54.8, 47.2. 11B NMR (128 MHz, Acetonitrile-d3): 7.66. LCMS purity UV = >99%, 
Ret. time = 14.76 min. HRMS-FTMS (m/z) found 286.0860, calcd for [C12H14
10BNO5Na]
+ 286.0857. 
2-Chloro-3-pyridyl MIDA boronate 2t. Made following General Method B. Yield: 67 mg (25 %). Made 
following General Method C. Yield: 220 mg (82 %). CAS Number 1309676-59-2. 1H NMR (500 MHz, 
Acetonitrile-d3): δ 8.39 (dd, J = 4.7, 1.8 Hz, 1H), 8.11 (dd, J=1.8, 7.4 Hz, 1H), 7.35 (dd, J = 7.4, 4.7 Hz, 
1H), 4.16 (d, J = 17.3 Hz, 2H), 4.05 (d, J = 17.3 Hz, 2H), 2.75 (s, 3H). 13C NMR (126 MHz, 
Acetonitrile-d3):
 169.3, 151.6, 146.6, 123.5, 111.0, 65.2, 49.3. 11B NMR (128 MHz, Acetonitrile-d3): 
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11.01. LCMS purity UV = >99%, Ret. time = 11.43 min. HRMS-FTMS (m/z) found 291.0309, calcd for 
[C10H10
10BClN2O4Na]
+ 291.0314. 
2,4-Dimethoxypyrimidine-5-MIDA boronate 2u. Made following General Method B. Yield: 245 mg 
(83%). Made following General Method C. Yield: 177 mg (60%). 1H NMR (500 MHz, Acetonitrile-d3): 
δ 8.38 (s, 1H), 4.08 (d, J = 17.0 Hz, 2H), 3.95 (s, 3H), 3.94 (d, J = 17.0 Hz, 2H), 3.91 (s, 3H), 2.66 (s, 
3H). 13C NMR (126 MHz, Acetonitrile-d3): δ 174.8, 169.3, 167.9, 164.9, 111.0, 64.0, 55.2, 54.3, 48.2. 
11B NMR (128 MHz, Acetonitrile-d3); δ 11.24. LCMS purity UV = 97%, Ret. time = 10.34 min. HRMS-
FTMS (m/z) found 296.1046, calcd for [C11H14
10BN3O6H]
+ 296.1048. 
2-Hydroxyphenyl MIDA boronate 2v. Made following General Method B. Yield: 105 mg (1 mmol scale, 
42 %). 1H NMR (500 MHz, DMSO-d6): δ 9.53 (s, 1H), 7.38 (dd, J = 7.3, 1.6 Hz, 1H), 7.17 (ddd, J = 
7.9, 7.3, 1.6 Hz, 1H), 6.80-6.73 (m, 2H), 4.32 (d, J = 17.0 Hz, 2H), 4.03 (d, J = 17.0 Hz, 2H), 2.63 (s, 
3H). 13C NMR (126 MHz, DMSO-d6): 169.3, 160.0, 134.0, 130.2, 118.7, 114.6, 63.1, 47.1. 
11B NMR 
(128 MHz, DMSO-d6): 11.80. LCMS purity UV = >99 %, Ret. time = 12.76 min. HRMS-FTMS (m/z) 
found 272.0702, calcd for [C11H12
10BNO5Na]
+ 272.0701. 
2-Fluorophenyl MIDA boronate 2w. Following General Method B. Yield: 208 mg (83%), 991 mg (5 
mmol scale, 79%). 1H NMR (500 MHz, Acetonitrile-d3): 7.59 (dd, J = 7.4 Hz, 1H), 7.49-7.41 (m, 1H), 
7.22 (dd, J = 7.4 Hz, 1H), 7.08 (dd, J = 10.4, 8.4 Hz, 1H), 4.12 (d, J = 17.1 Hz, 2H), 3.95 (d, J = 17.1 
Hz, 2H), 2.64 (s, 3H).  13C NMR (126 MHz, DMSO-d6): 168.9, 165.5 (d, J = 241.1 Hz), 134.7 (d, J = 
9.2 Hz), 131.6 (d, J = 8.7 Hz), 124.1 (d, J = 2.7 Hz), 114.9 (d, J = 24.8 Hz), 62.4 (d, J = 2.2 Hz), 47.5. 
19F NMR (376 MHz, DMSO-d6): -107.45 (m).
 11B NMR (128 MHz, Acetonitrile-d3): 10.48. LCMS 
purity UV = >99%, Ret. time = 14.72 min. HRMS-FTMS (m/z) found 274.0661, calcd for 
[C11H11
10BFNO4Na]
+ 274.0657. 
2,6-Dichlorophenyl MIDA boronate 2x. Following General Method B. Yield: 104 mg (35%). 1H NMR 
(500 MHz, Acetonitrile-d3): δ 7.40 (m, 1H), 7.34 – 7.29 (m, 2H), 4.15 (d, J = 17.4 Hz, 2H), 4.01 (d, J = 
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17.4 Hz, 2H), 2.83 (s, 3H). 13C NMR (126 MHz, Acetonitrile-d3): δ 169.2, 142.0, 132.4, 130.9, 65.4, 
49.7. 11B NMR (128 MHz, Acetonitrile-d3); δ 11.36.  LCMS purity UV = >99%, Ret. Time = 15.56 min. 
HRMS-FTMS (m/z) found 323.9967, calcd for [C11H10
10BCl2NO4Na]
+ 323.9972. 
4-Methoxyphenyl MIDA boronate 2z. Made following General Method C. Yield: 184 mg (70%). CAS 
Number 1257739-11-9. 1H NMR (500 MHz, Acetonitrile-d3) δ 7.42 (d, J = 8.6 Hz, 2H), 6.94 (d, J = 8.5 
Hz, 2H), 4.03 (d, J = 17.1 Hz, 2H), 3.86 (d, J = 17.1 Hz, 2H), 3.80 (s, 3H), 2.49 (s, 3H). 13C NMR (126 
MHz, Acetonitrile-d3) δ 169.6, 161.8, 134.9, 114.5, 62.7, 55.8, 48.4. 
11B NMR (128 MHz, Acetonitrile-
d3) δ 11.56. LCMS purity UV >99%, Ret. time = 14.36 min. HRMS-ESI (m/z) found 286.0869, calcd 
for [C12H14
10BNO5Na]
+ 286.0857. 
Supporting Information. Scanned 1H, 13C, 11B, 19F NMR spectra, where applicable, for all compounds 
are available. 
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